Michelle Lin – CEO and Hsu Chang – Senior Advisor, EpiSonica, Taiwan

Michelle Lin, CEO, and Hsu Chang, Senior Advisor of EpiSonica, highlight the innovative new solutions that the company has created for women’s health and medical imagining. The advanced technology will make impressive waves in ultrasound tumor ablation and breast cancer screening – meeting high unmet medical needs. They go on to share their strategy as a key startup shaping the way for Taiwan’s emerging medical device sector.  
EpiSonica has many competencies – two products, expertise, an innovative solution, and high success potential – so I am confident for the future outlook of the company.
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report